DJ Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rallied 5.19% to $5.67 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 12.16% to 17,124.97 and the Dow Jones Industrial Average rising 7.87% to 40,608.45.
This was the stock's fourth consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 90.84% below its 52-week high of $61.90, which the company achieved on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 0.24% to $4.13, Fortress Biotech Inc. (FBIO) rose 1.40% to $1.45, and Viking Therapeutics Inc. $(VKTX)$ rose 15.62% to $23.10.
Trading volume (307,928) eclipsed its 50-day average volume of 249,333.
Data source: Dow Jones Market Data, FactSet. Data compiled April 9, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 09, 2025 17:23 ET (21:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。